Rapid Generation of In-House Serological Assays Is Comparable to Commercial Kits Critical for Early Response to Pandemics: A Case With SARS-CoV-2.
Auerswald H, Eng C, Lay S, In S, Eng S, Vo HTM, Sith C, Cheng S, Delvallez G, Mich V, Meng N, Sovann L, Sidonn K, Vanhomwegen J, Cantaert T, Dussart P, Duong V, Karlsson EA.
Auerswald H, et al. Among authors: cheng s.
Front Med (Lausanne). 2022 May 6;9:864972. doi: 10.3389/fmed.2022.864972. eCollection 2022.
Front Med (Lausanne). 2022.
PMID: 35602487
Free PMC article.